Search Results 1081-1090 of 18603 for hepatitis

1. A Study of V940 Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002) - Mayo Clinic

   * Participants who are hepatitis B surface antigen (HBsAg) positive are eligible if they have received hepatitis B virus (HBV) antiviral therapy for at ...

2. A Study Using a New Drug, Nivolumab, in Combination With Chemotherapy Drugs to Treat a Type of Cancer Called Nasopharyngeal Carcinoma (NPC) - Mayo Clinic

   ... hepatitis B or hepatitis C, or active tuberculosis * Patients who have undergone solid organ or allogeneic hematopoietic transplant at any time * Due to ...

3. Long-term Safety and Effectiveness Study for Participants with Advanced Tumors who are Currently on Treatment or in Follow-up in a Pembrolizumab Trial - Mayo Clinic

   - Has a known history of human immunodeficiency virus (HIV) infection. - Has a known history of or is positive for hepatitis B or hepatitis C. For parent

4. Study to Evaluate Safety and Tolerability of XmAb13676 in Patients With CD20-expressing Hematologic Malignancies - Mayo Clinic

   hepatitis B DNA testing is negative and the patient is receiving hepatitis B reactivation prophylaxis with entecavir, tenofovir, or lamivudine. Patient is ...

5. Determining the Role of PTEN/AKT Signaling in Extrahepatic Cholangiocarcinoma Using a Novel Genetic Mouse Model - Mayo Clinic Research

   Hepatitis B-Associated Hepatocellular Carcinoma: Variation in Therapeutic Response Mediated by Viral Integration · Rab GTPases As Drivers of Lipid Droplet ...

6. Dr. Lionel Kankeu Fonkoua – diversity in clinical trials

   His study focuses on the immigrant African and Asian communities of Minnesota with a high prevalence of hepatitis-induced hepatocellular carcinoma — a type of.

7. A Study to Evaluate Entolimod on Immune System Aging in Healthy Geriatric Subjects Receiving Influenza Vaccination - Mayo Clinic

   Positive hepatitis C virus (HCV) antibody or positive HCV ribonucleic ... Positive hepatitis B surface antigen (HBsAg) and negative hepatitis B core ...

8. A Study of Modafinil for the Treatment of Fatigue in Patients with Primary Biliary Cirrhosis - Mayo Clinic

   ... hepatitis B or C infection, hemochromatosis, Wilson's disease, 1-antitrypsin deficiency, non-alcoholic steatohepatitis or sclerosing cholangitis; Treatment ...

9. A Study to Evaluate Tazemetostat and Pembrolizumab to Treat Advanced Urothelial Carcinoma - Mayo Clinic

   Patients with a known history of hepatitis B (defined as hepatitis B ... hepatitis B and hepatitis C is required unless mandated by local health authority.

10. Etranacogene dezaparvovec-drlb (intravenous route) - Side effects & uses - Mayo Clinic

    Make sure you tell your doctor if you have any other medical problems, especially: Liver disease (eg, cirrhosis, hepatic fibrosis, hepatitis B or C, non- ...